Page last updated: 2024-08-21

nsc 65346 and 5-iodotubercidin

nsc 65346 has been researched along with 5-iodotubercidin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzarini, J; Bergstrom, DE; Brattesani, AJ; De Clercq, E; Ogawa, MK; Reddy, PA; Schweickert, MJ1
Browne, CE; DaRe, JM; Erion, MD; Kopcho, JJ; Schanzer, JM; Ugarkar, BG; Wiesner, JB1
Debnath, B; Jha, T; Srikanth, K1
González, MP; Moldes del Carmen Terán, M1
Caballero, J; Fernández, M; González-Nilo, FD1
Bayle, ED; Fish, PV; Li, F; Schapira, M; Spurr, SS; Tempel, W; Vedadi, M; Yu, W1
Cheviet, T; Lefebvre-Tournier, I; Peyrottes, S; Wein, S1
Crespo, RA; Dang, Q; Dong, W; Guthrie, LM; Loesch, KA; O'Malley, T; Olsen, DB; Parish, T; Sacchettini, JC; Snavely, TC; Suzuki, T; Wang, W; You, L; Zhou, NE1

Reviews

1 review(s) available for nsc 65346 and 5-iodotubercidin

ArticleYear
Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
    Journal of medicinal chemistry, 2019, 09-26, Volume: 62, Issue:18

    Topics: Antimalarials; Biological Transport; Drug Design; Erythrocytes; Humans; Inhibitory Concentration 50; Malaria; Nucleosides; Nucleotides; Plasmodium falciparum; Purines; Pyrimidines

2019

Other Studies

7 other study(ies) available for nsc 65346 and 5-iodotubercidin

ArticleYear
Antiviral activity of C-5 substituted tubercidin analogues.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antiviral Agents; Chlorocebus aethiops; DNA Viruses; HeLa Cells; Humans; Mice; Pyrimidine Nucleosides; Rabbits; Ribonucleosides; RNA Viruses; Toyocamycin; Tubercidin

1984
Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues.
    Journal of medicinal chemistry, 2000, Jul-27, Volume: 43, Issue:15

    Topics: Adenosine Kinase; Animals; Anticonvulsants; Electroshock; Enzyme Inhibitors; Humans; Male; Rats; Recombinant Proteins; Seizures; Structure-Activity Relationship; Tubercidin

2000
QSAR study on adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues using the hansch approach.
    Bioorganic & medicinal chemistry letters, 2002, Mar-25, Volume: 12, Issue:6

    Topics: Adenosine Kinase; Biodegradation, Environmental; Hydrophobic and Hydrophilic Interactions; Ligands; Pyrimidines; Pyrroles; Quantitative Structure-Activity Relationship

2002
A TOPS-MODE approach to predict adenosine kinase inhibition.
    Bioorganic & medicinal chemistry letters, 2004, Jun-21, Volume: 14, Issue:12

    Topics: Adenosine Kinase; Enzyme Inhibitors; Models, Molecular; Predictive Value of Tests; Quantitative Structure-Activity Relationship

2004
A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues.
    Bioorganic & medicinal chemistry, 2008, May-01, Volume: 16, Issue:9

    Topics: Adenosine Kinase; Computer Simulation; Databases, Factual; Enzyme Inhibitors; Models, Chemical; Models, Molecular; Molecular Structure; Nucleosides; Pyrimidines; Pyrroles; Quantitative Structure-Activity Relationship; Reproducibility of Results; Stereoisomerism

2008
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
    Bioorganic & medicinal chemistry letters, 2016, 09-15, Volume: 26, Issue:18

    Topics: Crystallography; Enzyme Inhibitors; Halogens; Histone-Lysine N-Methyltransferase; Methyltransferases; Nitriles; Small Molecule Libraries; Structure-Activity Relationship

2016
Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase.
    Journal of medicinal chemistry, 2019, 05-09, Volume: 62, Issue:9

    Topics: Adenosine; Adenosine Kinase; Animals; Antitubercular Agents; Catalytic Domain; Drug Design; Female; Mice; Molecular Structure; Mycobacterium tuberculosis; Protein Binding; Protein Kinase Inhibitors; Structure-Activity Relationship

2019